New Zealand

New Zealand

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.9 (0.78 - 1.01) 2019 Modelled IHME
0.91 (0.80 - 1.02) 2018 Modelled IHME
0.91 (0.80 - 1.03) 2017 Modelled IHME
0.91 (0.80 - 1.01) 2016 Modelled IHME
0.9 (0.79 - 1.01) 2015 Modelled IHME
0.91 (0.80 - 1.01) 2014 Modelled IHME
0.92 (0.81 - 1.03) 2013 Modelled IHME
0.94 (0.82 - 1.05) 2012 Modelled IHME
0.95 (0.83 - 1.07) 2011 Modelled IHME
0.97 (0.84 - 1.09) 2010 Modelled IHME
0.98 (0.86 - 1.11) 2009 Modelled IHME
0.99 (0.87 - 1.12) 2008 Modelled IHME
1.01 (0.88 - 1.13) 2007 Modelled IHME
1.02 (0.89 - 1.16) 2006 Modelled IHME
1.03 (0.90 - 1.17) 2005 Modelled IHME
1.05 (0.92 - 1.19) 2004 Modelled IHME
1.06 (0.93 - 1.20) 2003 Modelled IHME
1.08 (0.95 - 1.21) 2002 Modelled IHME
1.09 (0.96 - 1.23) 2001 Modelled IHME
1.11 (0.97 - 1.25) 2000 Modelled IHME
1.13 (0.98 - 1.27) 1999 Modelled IHME
1.15 (1 - 1.29) 1998 Modelled IHME
1.17 (1.01 - 1.31) 1997 Modelled IHME
1.18 (1.03 - 1.34) 1996 Modelled IHME
1.2 (1.04 - 1.37) 1995 Modelled IHME
1.22 (1.06 - 1.39) 1994 Modelled IHME
1.24 (1.07 - 1.41) 1993 Modelled IHME
1.26 (1.09 - 1.43) 1992 Modelled IHME
1.27 (1.10 - 1.47) 1991 Modelled IHME
1.29 (1.11 - 1.50) 1990 Modelled IHME
3.13 (2.51 - 3.89) 2015 Modelled WHO
2 (1.40 - 3.40) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.07 (0.05 - 0.08) 2019 Modelled IHME
0.07 (0.05 - 0.09) 2018 Modelled IHME
0.07 (0.05 - 0.09) 2017 Modelled IHME
0.07 (0.05 - 0.09) 2016 Modelled IHME
0.07 (0.05 - 0.09) 2015 Modelled IHME
0.07 (0.06 - 0.09) 2014 Modelled IHME
0.07 (0.06 - 0.09) 2013 Modelled IHME
0.07 (0.06 - 0.09) 2012 Modelled IHME
0.07 (0.06 - 0.09) 2011 Modelled IHME
0.08 (0.06 - 0.10) 2010 Modelled IHME
0.08 (0.06 - 0.10) 2009 Modelled IHME
0.09 (0.07 - 0.11) 2008 Modelled IHME
0.09 (0.07 - 0.12) 2007 Modelled IHME
0.1 (0.08 - 0.13) 2006 Modelled IHME
0.1 (0.08 - 0.13) 2005 Modelled IHME
0.11 (0.08 - 0.14) 2004 Modelled IHME
0.11 (0.09 - 0.14) 2003 Modelled IHME
0.12 (0.09 - 0.15) 2002 Modelled IHME
0.12 (0.09 - 0.15) 2001 Modelled IHME
0.12 (0.10 - 0.16) 2000 Modelled IHME
0.13 (0.10 - 0.16) 1999 Modelled IHME
0.13 (0.10 - 0.17) 1998 Modelled IHME
0.14 (0.11 - 0.18) 1997 Modelled IHME
0.15 (0.11 - 0.19) 1996 Modelled IHME
0.15 (0.12 - 0.20) 1995 Modelled IHME
0.17 (0.13 - 0.22) 1994 Modelled IHME
0.18 (0.14 - 0.23) 1993 Modelled IHME
0.2 (0.16 - 0.26) 1992 Modelled IHME
0.22 (0.17 - 0.28) 1991 Modelled IHME
0.25 (0.19 - 0.31) 1990 Modelled IHME
1.2 (0.83 - 1.70) 2015 Modelled WHO
0.2 (0 - 1.20) 2009 Survey/reported WHO WPRO, Woodring J et al, 2017
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
44,147 (38,049 - 51,096) 1990 Modelled IHME
43,999 (37,939 - 50,709) 1991 Modelled IHME
43,903 (37,960 - 50,121) 1992 Modelled IHME
43,824 (37,921 - 49,965) 1993 Modelled IHME
43,732 (37,850 - 49,927) 1994 Modelled IHME
43,599 (37,694 - 49,718) 1995 Modelled IHME
43,382 (37,612 - 49,168) 1996 Modelled IHME
43,055 (37,452 - 48,476) 1997 Modelled IHME
42,689 (37,192 - 48,053) 1998 Modelled IHME
42,343 (36,845 - 47,669) 1999 Modelled IHME
42,057 (36,789 - 47,349) 2000 Modelled IHME
41,848 (36,582 - 47,114) 2001 Modelled IHME
41,738 (36,623 - 46,976) 2002 Modelled IHME
41,710 (36,576 - 47,022) 2003 Modelled IHME
41,730 (36,532 - 47,302) 2004 Modelled IHME
41,761 (36,502 - 47,480) 2005 Modelled IHME
41,789 (36,672 - 47,351) 2006 Modelled IHME
41,782 (36,628 - 47,076) 2007 Modelled IHME
41,718 (36,526 - 46,922) 2008 Modelled IHME
41,584 (36,286 - 46,815) 2009 Modelled IHME
41,384 (36,010 - 46,680) 2010 Modelled IHME
41,034 (35,815 - 46,095) 2011 Modelled IHME
40,548 (35,469 - 45,425) 2012 Modelled IHME
40,073 (35,122 - 44,886) 2013 Modelled IHME
39,766 (34,845 - 44,371) 2014 Modelled IHME
39,783 (34,793 - 44,480) 2015 Modelled IHME
40,211 (35,303 - 44,839) 2016 Modelled IHME
40,638 (35,724 - 45,805) 2017 Modelled IHME
40,668 (35,639 - 45,662) 2018 Modelled IHME
40,382 (35,188 - 45,511) 2019 Modelled IHME
95,000 (66,000 - 158,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.96 (1.71 - 2.21) 2019 Modelled IHME
1.93 (1.70 - 2.17) 2018 Modelled IHME
1.88 (1.65 - 2.11) 2017 Modelled IHME
1.89 (1.66 - 2.11) 2016 Modelled IHME
1.89 (1.67 - 2.12) 2015 Modelled IHME
1.9 (1.68 - 2.12) 2014 Modelled IHME
1.86 (1.64 - 2.08) 2013 Modelled IHME
1.84 (1.64 - 2.05) 2012 Modelled IHME
1.81 (1.60 - 2.01) 2011 Modelled IHME
1.76 (1.56 - 1.95) 2010 Modelled IHME
1.72 (1.53 - 1.93) 2009 Modelled IHME
1.67 (1.49 - 1.86) 2008 Modelled IHME
1.63 (1.46 - 1.81) 2007 Modelled IHME
1.58 (1.41 - 1.75) 2006 Modelled IHME
1.53 (1.36 - 1.70) 2005 Modelled IHME
1.52 (1.37 - 1.69) 2004 Modelled IHME
1.51 (1.35 - 1.68) 2003 Modelled IHME
1.51 (1.35 - 1.67) 2002 Modelled IHME
1.47 (1.31 - 1.63) 2001 Modelled IHME
1.46 (1.30 - 1.61) 2000 Modelled IHME
1.47 (1.32 - 1.63) 1999 Modelled IHME
1.43 (1.29 - 1.58) 1998 Modelled IHME
1.44 (1.29 - 1.60) 1997 Modelled IHME
1.43 (1.28 - 1.59) 1996 Modelled IHME
1.42 (1.27 - 1.57) 1995 Modelled IHME
1.38 (1.24 - 1.54) 1994 Modelled IHME
1.42 (1.28 - 1.58) 1993 Modelled IHME
1.44 (1.30 - 1.61) 1992 Modelled IHME
1.48 (1.33 - 1.65) 1991 Modelled IHME
1.53 (1.37 - 1.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
88 (77 - 99) 2019 Modelled IHME
87 (76 - 97) 2018 Modelled IHME
83 (74 - 94) 2017 Modelled IHME
83 (74 - 93) 2016 Modelled IHME
83 (74 - 93) 2015 Modelled IHME
83 (74 - 93) 2014 Modelled IHME
81 (72 - 90) 2013 Modelled IHME
80 (71 - 89) 2012 Modelled IHME
78 (69 - 86) 2011 Modelled IHME
75 (67 - 83) 2010 Modelled IHME
73 (65 - 82) 2009 Modelled IHME
70 (63 - 78) 2008 Modelled IHME
68 (61 - 75) 2007 Modelled IHME
65 (58 - 72) 2006 Modelled IHME
62 (55 - 69) 2005 Modelled IHME
61 (54 - 67) 2004 Modelled IHME
59 (53 - 66) 2003 Modelled IHME
58 (52 - 65) 2002 Modelled IHME
56 (50 - 62) 2001 Modelled IHME
55 (49 - 61) 2000 Modelled IHME
55 (50 - 61) 1999 Modelled IHME
53 (48 - 59) 1998 Modelled IHME
53 (48 - 59) 1997 Modelled IHME
52 (47 - 58) 1996 Modelled IHME
51 (46 - 57) 1995 Modelled IHME
50 (45 - 55) 1994 Modelled IHME
50 (45 - 56) 1993 Modelled IHME
50 (45 - 56) 1992 Modelled IHME
51 (46 - 57) 1991 Modelled IHME
52 (47 - 58) 1990 Modelled IHME
195 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
15 (13 - 18) 2019 Modelled IHME
15 (12 - 18) 2018 Modelled IHME
15 (13 - 18) 2017 Modelled IHME
15 (13 - 18) 2016 Modelled IHME
15 (13 - 18) 2015 Modelled IHME
15 (13 - 18) 2014 Modelled IHME
15 (13 - 18) 2013 Modelled IHME
16 (13 - 19) 2012 Modelled IHME
16 (13 - 19) 2011 Modelled IHME
16 (13 - 19) 2010 Modelled IHME
16 (13 - 19) 2009 Modelled IHME
16 (13 - 19) 2008 Modelled IHME
16 (13 - 19) 2007 Modelled IHME
16 (13 - 19) 2006 Modelled IHME
16 (13 - 19) 2005 Modelled IHME
16 (13 - 19) 2004 Modelled IHME
16 (13 - 19) 2003 Modelled IHME
16 (13 - 19) 2002 Modelled IHME
16 (13 - 19) 2001 Modelled IHME
16 (14 - 19) 2000 Modelled IHME
16 (14 - 19) 1999 Modelled IHME
16 (14 - 19) 1998 Modelled IHME
16 (14 - 19) 1997 Modelled IHME
16 (13 - 19) 1996 Modelled IHME
16 (13 - 19) 1995 Modelled IHME
16 (14 - 19) 1994 Modelled IHME
16 (14 - 20) 1993 Modelled IHME
17 (14 - 20) 1992 Modelled IHME
17 (14 - 20) 1991 Modelled IHME
17 (14 - 21) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
93 2018 Survey/reported WHO/UNICEF
94 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
93 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
90 2008 Survey/reported WHO/UNICEF
88 2007 Survey/reported WHO/UNICEF
87 2006 Survey/reported WHO/UNICEF
87 2005 Survey/reported WHO/UNICEF
88 2004 Survey/reported WHO/UNICEF
89 2003 Survey/reported WHO/UNICEF
89 2002 Survey/reported WHO/UNICEF
90 2001 Survey/reported WHO/UNICEF
90 2000 Survey/reported WHO/UNICEF
89 1999 Survey/reported WHO/UNICEF
87 1998 Survey/reported WHO/UNICEF
99 1997 Survey/reported WHO/UNICEF
94 1996 Survey/reported WHO/UNICEF
88 1995 Survey/reported WHO/UNICEF
81 1994 Survey/reported WHO/UNICEF
74 1993 Survey/reported WHO/UNICEF
67 1992 Survey/reported WHO/UNICEF
92 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
124 (93 - 185) 2016 Survey/reported Noller G and Leafe K, 2016; New Zealdn Ministry of Health, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
48.1 (44.30 - 51.80) 2013 Survey/reported Noller G and Leafe K, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.78 (0.63 - 0.95) 2019 Modelled IHME
0.78 (0.63 - 0.94) 2018 Modelled IHME
0.77 (0.62 - 0.94) 2017 Modelled IHME
0.76 (0.61 - 0.93) 2016 Modelled IHME
0.75 (0.60 - 0.92) 2015 Modelled IHME
0.75 (0.61 - 0.92) 2014 Modelled IHME
0.75 (0.61 - 0.92) 2013 Modelled IHME
0.75 (0.61 - 0.92) 2012 Modelled IHME
0.75 (0.61 - 0.91) 2011 Modelled IHME
0.75 (0.60 - 0.92) 2010 Modelled IHME
0.75 (0.61 - 0.91) 2009 Modelled IHME
0.75 (0.61 - 0.91) 2008 Modelled IHME
0.74 (0.61 - 0.91) 2007 Modelled IHME
0.74 (0.60 - 0.91) 2006 Modelled IHME
0.74 (0.60 - 0.91) 2005 Modelled IHME
0.74 (0.60 - 0.90) 2004 Modelled IHME
0.74 (0.60 - 0.90) 2003 Modelled IHME
0.73 (0.59 - 0.90) 2002 Modelled IHME
0.73 (0.59 - 0.89) 2001 Modelled IHME
0.73 (0.59 - 0.90) 2000 Modelled IHME
0.73 (0.59 - 0.90) 1999 Modelled IHME
0.74 (0.59 - 0.90) 1998 Modelled IHME
0.74 (0.60 - 0.91) 1997 Modelled IHME
0.74 (0.60 - 0.91) 1996 Modelled IHME
0.75 (0.60 - 0.92) 1995 Modelled IHME
0.75 (0.60 - 0.91) 1994 Modelled IHME
0.75 (0.60 - 0.92) 1993 Modelled IHME
0.75 (0.60 - 0.92) 1992 Modelled IHME
0.74 (0.60 - 0.92) 1991 Modelled IHME
0.74 (0.60 - 0.92) 1990 Modelled IHME
1 (0.60 - 1.30) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.9 (0.80 - 2.20) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
71.9 (63.20 - 80.60) 2015 Modelled
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
25,412 (20,436 - 31,326) 1990 Modelled IHME
25,718 (20,692 - 31,643) 1991 Modelled IHME
26,048 (21,002 - 31,970) 1992 Modelled IHME
26,385 (21,274 - 32,377) 1993 Modelled IHME
26,718 (21,528 - 32,723) 1994 Modelled IHME
27,033 (21,724 - 33,179) 1995 Modelled IHME
27,258 (21,866 - 33,345) 1996 Modelled IHME
27,352 (22,043 - 33,459) 1997 Modelled IHME
27,399 (22,076 - 33,476) 1998 Modelled IHME
27,479 (22,238 - 33,614) 1999 Modelled IHME
27,665 (22,406 - 33,960) 2000 Modelled IHME
27,987 (22,606 - 34,225) 2001 Modelled IHME
28,434 (23,024 - 34,660) 2002 Modelled IHME
28,962 (23,396 - 35,283) 2003 Modelled IHME
29,513 (23,802 - 36,005) 2004 Modelled IHME
30,024 (24,167 - 36,702) 2005 Modelled IHME
30,486 (24,734 - 37,279) 2006 Modelled IHME
30,906 (25,128 - 37,912) 2007 Modelled IHME
31,276 (25,447 - 38,327) 2008 Modelled IHME
31,594 (25,702 - 38,699) 2009 Modelled IHME
31,872 (25,817 - 39,124) 2010 Modelled IHME
32,113 (26,071 - 39,309) 2011 Modelled IHME
32,323 (26,250 - 39,600) 2012 Modelled IHME
32,516 (26,398 - 39,844) 2013 Modelled IHME
32,714 (26,581 - 40,155) 2014 Modelled IHME
32,931 (26,585 - 40,401) 2015 Modelled IHME
33,476 (27,041 - 40,987) 2016 Modelled IHME
34,169 (27,513 - 41,770) 2017 Modelled IHME
34,667 (27,962 - 42,232) 2018 Modelled IHME
35,096 (28,247 - 42,802) 2019 Modelled IHME
48,000 (30,000 - 62,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
4.69 (4.19 - 5.21) 2019 Modelled IHME
4.64 (4.15 - 5.16) 2018 Modelled IHME
4.47 (3.99 - 4.94) 2017 Modelled IHME
4.44 (3.97 - 4.93) 2016 Modelled IHME
4.42 (3.94 - 4.91) 2015 Modelled IHME
4.4 (3.93 - 4.89) 2014 Modelled IHME
4.27 (3.82 - 4.73) 2013 Modelled IHME
4.21 (3.78 - 4.67) 2012 Modelled IHME
4.13 (3.70 - 4.56) 2011 Modelled IHME
3.98 (3.59 - 4.40) 2010 Modelled IHME
3.93 (3.56 - 4.35) 2009 Modelled IHME
3.86 (3.49 - 4.27) 2008 Modelled IHME
3.78 (3.42 - 4.19) 2007 Modelled IHME
3.68 (3.34 - 4.07) 2006 Modelled IHME
3.6 (3.28 - 3.99) 2005 Modelled IHME
3.59 (3.28 - 3.96) 2004 Modelled IHME
3.57 (3.24 - 3.93) 2003 Modelled IHME
3.6 (3.26 - 3.96) 2002 Modelled IHME
3.49 (3.17 - 3.83) 2001 Modelled IHME
3.44 (3.13 - 3.77) 2000 Modelled IHME
3.45 (3.15 - 3.79) 1999 Modelled IHME
3.33 (3.04 - 3.64) 1998 Modelled IHME
3.38 (3.08 - 3.69) 1997 Modelled IHME
3.36 (3.07 - 3.66) 1996 Modelled IHME
3.31 (3.01 - 3.61) 1995 Modelled IHME
3.17 (2.88 - 3.47) 1994 Modelled IHME
3.12 (2.85 - 3.41) 1993 Modelled IHME
3.03 (2.77 - 3.31) 1992 Modelled IHME
2.95 (2.68 - 3.24) 1991 Modelled IHME
2.85 (2.58 - 3.14) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
211 (188 - 234) 2019 Modelled IHME
208 (186 - 231) 2018 Modelled IHME
199 (178 - 220) 2017 Modelled IHME
196 (176 - 218) 2016 Modelled IHME
195 (173 - 216) 2015 Modelled IHME
192 (172 - 214) 2014 Modelled IHME
186 (166 - 206) 2013 Modelled IHME
182 (163 - 202) 2012 Modelled IHME
177 (159 - 196) 2011 Modelled IHME
170 (153 - 188) 2010 Modelled IHME
167 (151 - 184) 2009 Modelled IHME
162 (147 - 179) 2008 Modelled IHME
157 (142 - 174) 2007 Modelled IHME
151 (137 - 167) 2006 Modelled IHME
146 (133 - 161) 2005 Modelled IHME
143 (131 - 158) 2004 Modelled IHME
140 (127 - 154) 2003 Modelled IHME
139 (126 - 153) 2002 Modelled IHME
133 (121 - 147) 2001 Modelled IHME
130 (118 - 143) 2000 Modelled IHME
130 (118 - 142) 1999 Modelled IHME
124 (113 - 136) 1998 Modelled IHME
125 (114 - 136) 1997 Modelled IHME
123 (112 - 134) 1996 Modelled IHME
120 (109 - 131) 1995 Modelled IHME
114 (103 - 124) 1994 Modelled IHME
110 (101 - 121) 1993 Modelled IHME
106 (97 - 116) 1992 Modelled IHME
102 (92 - 112) 1991 Modelled IHME
98 (88 - 107) 1990 Modelled IHME
37 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
31 (28 - 35) 2019 Modelled IHME
32 (28 - 36) 2018 Modelled IHME
32 (28 - 36) 2017 Modelled IHME
31 (28 - 35) 2016 Modelled IHME
31 (27 - 34) 2015 Modelled IHME
30 (27 - 34) 2014 Modelled IHME
30 (26 - 34) 2013 Modelled IHME
30 (26 - 34) 2012 Modelled IHME
30 (26 - 34) 2011 Modelled IHME
30 (26 - 33) 2010 Modelled IHME
30 (26 - 33) 2009 Modelled IHME
30 (26 - 33) 2008 Modelled IHME
30 (26 - 33) 2007 Modelled IHME
30 (26 - 33) 2006 Modelled IHME
30 (26 - 33) 2005 Modelled IHME
30 (26 - 33) 2004 Modelled IHME
30 (26 - 33) 2003 Modelled IHME
30 (26 - 34) 2002 Modelled IHME
30 (26 - 34) 2001 Modelled IHME
30 (26 - 34) 2000 Modelled IHME
30 (26 - 33) 1999 Modelled IHME
29 (26 - 33) 1998 Modelled IHME
29 (26 - 33) 1997 Modelled IHME
29 (26 - 33) 1996 Modelled IHME
29 (25 - 33) 1995 Modelled IHME
29 (25 - 32) 1994 Modelled IHME
28 (25 - 32) 1993 Modelled IHME
28 (25 - 32) 1992 Modelled IHME
28 (25 - 32) 1991 Modelled IHME
28 (25 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
124 (93 - 185) 2016 Survey/reported Noller G and Leafe K, 2016; New Zealdn Ministry of Health, 2014
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
48.1 (44.30 - 51.80) 2013 Survey/reported Noller G and Leafe K, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
Risk-based
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
Many (31-60%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
88
2019
(77 - 99)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
211
2019
(188 - 234)
IHME

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners